Literature DB >> 20692628

Pulmonary hypertension in chronic neonatal lung disease.

Michael Farquhar1, Dominic A Fitzgerald.   

Abstract

Pulmonary hypertension is an uncommon but significantly challenging complication of chronic neonatal lung disease [CNLD] as it occurs in the "new bronchopulmonary dysplasia [BPD]". The presence of pulmonary hypertension may be sub-clinical and is often overlooked as it is not considered in all but the more severe cases of children with CNLD. Whilst the mainstays of therapy are supplemental oxygen and time and the majority of children will have resolution of their pulmonary hypertension with lung growth, the advent of newer pharmacological treatments has offered stability and perhaps a better prognosis for more severe cases of pulmonary hypertension. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20692628     DOI: 10.1016/j.prrv.2010.05.001

Source DB:  PubMed          Journal:  Paediatr Respir Rev        ISSN: 1526-0542            Impact factor:   2.726


  17 in total

1.  Fetal origins of neonatal lung disease: understanding the pathogenesis of bronchopulmonary dysplasia.

Authors:  Karen K Mestan; Robin H Steinhorn
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-09-30       Impact factor: 5.464

Review 2.  Frontiers in pulmonary hypertension in infants and children with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Lewis H Romer; Bridget D Stuart; John D Coulson; Allen D Everett; Edward E Lawson; Joel I Brenner; Anna T Brown; Melanie K Nies; Priya Sekar; Lawrence M Nogee; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2012-07-06

3.  Prospective analysis of pulmonary hypertension in extremely low birth weight infants.

Authors:  Ramachandra Bhat; Ariel A Salas; Chris Foster; Waldemar A Carlo; Namasivayam Ambalavanan
Journal:  Pediatrics       Date:  2012-02-06       Impact factor: 7.124

4.  Refractory pulmonary hypertension following extremely preterm birth: paradoxical improvement in oxygenation after atrial septostomy.

Authors:  Hiroki Saitsu; Osuke Iwata; Junichiro Okada; Akiko Hirose; Hiroshi Kanda; Toyojiro Matsuishi; Kenji Suda; Yasuki Maeno
Journal:  Eur J Pediatr       Date:  2013-08-03       Impact factor: 3.183

5.  Evidence of Echocardiographic Markers of Pulmonary Vascular Disease in Asymptomatic Infants Born Preterm at One Year of Age.

Authors:  Philip T Levy; Meghna D Patel; Swati Choudhry; Aaron Hamvas; Gautam K Singh
Journal:  J Pediatr       Date:  2018-04-03       Impact factor: 4.406

Review 6.  Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents.

Authors:  Nicolas F M Porta; Robin H Steinhorn
Journal:  Clin Perinatol       Date:  2012-03       Impact factor: 3.430

Review 7.  The genetic predisposition to bronchopulmonary dysplasia.

Authors:  Kun-Hsing Yu; Jingjing Li; Michael Snyder; Gary M Shaw; Hugh M O'Brodovich
Journal:  Curr Opin Pediatr       Date:  2016-06       Impact factor: 2.856

Review 8.  Pharmacotherapy for pulmonary hypertension.

Authors:  Robin H Steinhorn
Journal:  Pediatr Clin North Am       Date:  2012-08-26       Impact factor: 3.278

Review 9.  Pulmonary hypertension in bronchopulmonary dysplasia.

Authors:  Sara K Berkelhamer; Karen K Mestan; Robin H Steinhorn
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

10.  Effectiveness of positive pressure ventilation during newborn care unit evacuation.

Authors:  Nathan Timm; Sharon Farra; Elaine T Miller; Matthew Gneuhs; Whittney Brady; Cheryl Marshall; Ashley Simon
Journal:  J Neonatal Nurs       Date:  2017-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.